Physician

Jonathan Lee Bayuk, DO

According to 2025 Medicare claims, Jonathan Bayuk, DO (NPI: 1588637102) practices allergy/immunology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is ALLERGY AND IMMUNOLOGY ASSOCIATES OF NEW ENGLAND, LLC (NPI: 1538574082; TIN: 465716469) and primary practice location at 01062-2003.

Bayuk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 929 traditional Medicare patients, billed 20,554 HCPCS/CPT codes, and received $260,750 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,172 prescription claims across 407 beneficiaries totaling $2,989,114 in drug costs, led by Xolair (Omalizumab). DME data shows 655 claims. Open Payments data shows 218 records totaling $39,360. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $144,895 to $260,750. Similarly, Part D prescription costs have moved sharply higher in recent years, from $221,165 to $2,989,114. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,026 and ending at $10,634.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$145K$290K2015 Medicare payment: $144,895 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $184,159 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $125,372 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $120,372 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $97,547 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $130,210 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $289,932 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $265,365 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $263,878 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $260,750 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201540613,567$144,895
201653716,678$184,159
201747510,839$125,372
201849810,638$120,372
20194838,654$97,547
20204696,199$130,210
202192717,716$289,932
202286917,432$265,365
202389017,616$263,878
202492920,554$260,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $221,165 (USD; Tot_Drug_Cst)2016 Drug cost: $367,707 (USD; Tot_Drug_Cst)2017 Drug cost: $659,656 (USD; Tot_Drug_Cst)2018 Drug cost: $713,832 (USD; Tot_Drug_Cst)2019 Drug cost: $1,165,532 (USD; Tot_Drug_Cst)2020 Drug cost: $1,253,568 (USD; Tot_Drug_Cst)2021 Drug cost: $1,600,764 (USD; Tot_Drug_Cst)2022 Drug cost: $1,592,348 (USD; Tot_Drug_Cst)2023 Drug cost: $2,614,263 (USD; Tot_Drug_Cst)2024 Drug cost: $2,989,114 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015175893$221,165
20162301,058$367,707
20172411,125$659,656
20182321,231$713,832
20192311,352$1,165,532
20202621,479$1,253,568
20212711,500$1,600,764
20222841,602$1,592,348
20233592,018$2,614,263
20244072,172$2,989,114

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$583K$1.2M2015 Medicare payment: $365,178 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $522,493 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $460,128 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $633,268 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $636,436 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $638,109 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $731,137 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,165,704 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,163,511 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,111,699 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R301$365,178
2016N/R437$522,493
201712463$460,128
201811559$633,268
2019N/R538$636,436
202011514$638,109
2021N/R531$731,137
2022N/R576$1,165,704
202312662$1,163,511
202440655$1,111,699

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9292$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more331547$87
95165Professional service for preparation and provision of 1 or more antigens5579,666$10
95117Professional service for multiple injections of allergen2972,580$8
95115Professional service for single injection of allergen101482$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab1233,136$493,309
GammakedImmune Globul G/Gly/Iga Avg 46391,092$420,560
Dupixent SyringeDupilumab792,240$307,409
Dupixent PenDupilumab802,240$302,834
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5020420$269,050

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulinNN/R67$335,025
J1559Injection, immune globulin (hizentra), 100 mgNN/R48$187,360
J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mgNN/R32$176,991
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R55$148,972
J1555Injection, immune globulin (cuvitru), 100 mgNN/R13$82,564

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.218$39,360AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jonathan Lee Bayuk, DO?

Tedicare shows public-source Medicare data for Jonathan Lee Bayuk, DO (NPI 1588637102), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Lee Bayuk, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jonathan Lee Bayuk, DO?

Jonathan Lee Bayuk, DO is linked to ALLERGY AND IMMUNOLOGY ASSOCIATES OF NEW ENGLAND, LLC (billing NPI 1538574082) in the available physician profile data.

Does Jonathan Lee Bayuk, DO have Open Payments data?

Jonathan Lee Bayuk, DO has 218 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.